Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Comorbidity and some markers of cardiovascular disorders in disabled COPD patients

Svitlana Panina, Nataliya Sanina, Nataliia Gondulenko, Khizhnyak Galyna, Tetyana Igumnova
European Respiratory Journal 2012 40: P531; DOI:
Svitlana Panina
1Therapy, SI "Ukrainian State Institute of Medical and Social Problems of Disability of MoPH of Ukraine", Dnipropetrovs'k, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nataliya Sanina
1Therapy, SI "Ukrainian State Institute of Medical and Social Problems of Disability of MoPH of Ukraine", Dnipropetrovs'k, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nataliia Gondulenko
1Therapy, SI "Ukrainian State Institute of Medical and Social Problems of Disability of MoPH of Ukraine", Dnipropetrovs'k, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khizhnyak Galyna
2Clinical Diagnostic Laboratory, SI "Ukrainian State Institute of Medical and Social Problems of Disability of MoPH of Ukraine", Dnipropetrovs'k, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetyana Igumnova
1Therapy, SI "Ukrainian State Institute of Medical and Social Problems of Disability of MoPH of Ukraine", Dnipropetrovs'k, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: To assess the comorbidity level and its correlations with markers of cardiovascular disorders in disabled COPD patients.

Methods: A retrospective analysis of 53 disabled patients' medical documentation with COPD II and III stages was performed (age 55,6±1,8, 40 male). The complex assessment of comorbidity level was performed by Charlson index (CI) and BODE-index.

Results: Most of patients (70,5%) had comorbidity level of 2-3 points by CI, so their 10-year prognostic survival diminished to 10-23% compared with healthy individuals. 11.8% of patients had a CI value equal to 5 points, and 5.9% - equal to 8 points, which is extremely high. One-point comorbidity was recorded in only 5,9% of patients. The CI was significantly correlated with Ketle's index (r = 0,87, p <0,05), the level of total cholesterol (r = 0,71, p <0,05), plasma β-globulins level (r = -0,71, p <0,05), 6-minute walk distance (r = -0,72, p <0,05), and the size of the left atrium of the heart (r = 0,70, p <0,05). As for the BODE-index, 38.9% of patients had its value laying in the range of 4-7 points, indicating a progressive decrease in survival of these patients by 40% or more compared with healthy individuals. The correlation analysis showed a direct reliable link of BODE-index and CI (r = 0,76, p <0,05).

Thus, patients with COPD have a high level of comorbidity, which is closely related to some markers of cardiovascular diseases, protein metabolism disorders, and physical exercise tolerance. The received data suggest that in rehabilitation of COPD patients we should focus on treatment of comorbid conditions in order to increase the life expectancy of patients and reduce the risk of their mortality.

  • COPD - management
  • Comorbidities
  • Epidemiology
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comorbidity and some markers of cardiovascular disorders in disabled COPD patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Comorbidity and some markers of cardiovascular disorders in disabled COPD patients
Svitlana Panina, Nataliya Sanina, Nataliia Gondulenko, Khizhnyak Galyna, Tetyana Igumnova
European Respiratory Journal Sep 2012, 40 (Suppl 56) P531;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Comorbidity and some markers of cardiovascular disorders in disabled COPD patients
Svitlana Panina, Nataliya Sanina, Nataliia Gondulenko, Khizhnyak Galyna, Tetyana Igumnova
European Respiratory Journal Sep 2012, 40 (Suppl 56) P531;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Prevalence and clinical correlates of patient-reported autonomic symptoms among subjects with COPD
  • Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD
  • Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD
Show more 1.12 Clinical Problems - COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society